{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:40:13Z","timestamp":1761100813837},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Hematology"],"published-print":{"date-parts":[[2005,10,1]]},"DOI":"10.1532\/ijh97.04195","type":"journal-article","created":{"date-parts":[[2005,10,4]],"date-time":"2005-10-04T21:02:44Z","timestamp":1128459764000},"page":"262-265","source":"Crossref","is-referenced-by-count":12,"title":["Extramedullary Leukemic Relapses following Hematopoietic Stem Cell Transplantation with Nonmyeloablative Conditioning"],"prefix":"10.1007","volume":"82","author":[{"given":"Guillermo J.","family":"Ruiz-Arg\u00fcelles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"b David","family":"G\u00f3mez-Almaguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"c Jorge","family":"Vela-Ojeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"d Amelia","family":"Morales-Toquero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f3se David","family":"G\u00f3mez-Rangel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam A.","family":"Garc\u00eda-Ruiz-Esparza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Briceida","family":"L\u00f3pez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga G.","family":"Cant\u00fa-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9sar H.","family":"Guti\u00e9rrez-Aguirrec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"E00001","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/cncr.11240","volume":"97","author":"Tsimberidou, AM","year":"2003","unstructured":"Tsimberidou AM, Stavroyianni N, Viniou N, and the Hellenic Cooperative Group. Comparison of allogeneic stem cell transplantation, high-dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia. Cancer. 2003;97:1721-1731.","journal-title":"Cancer."},{"key":"E00002","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF02982597","volume":"77","author":"Georges, G","year":"2003","unstructured":"Georges G, Storb R. Review of \"minitransplantation\": nonmyeloablative allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2003;77:3-14.","journal-title":"Int J Hematol."},{"key":"E00003","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/107327480301000104","volume":"10","author":"Djulbegovic, B","year":"2003","unstructured":"Djulbegovic B, Seidenfeld J, Bonnell C, Kumar A. Nonmyeloablative allogeneic stem-cell transplantation for hematologic malignancies: a systematic review. Cancer Control. 2003;10:17-31.","journal-title":"Cancer Control."},{"key":"E00004","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","volume":"91","author":"Slavin, S","year":"1998","unstructured":"Slavin S, Nagler A, Naparstek E, et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematological diseases. Blood. 1998;91:756-763.","journal-title":"Blood."},{"key":"E00005","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V89.12.4531","volume":"89","author":"Giralt, S","year":"1997","unstructured":"Giralt S, Estey E, Albitar M, et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood. 1997;89:4531-4536.","journal-title":"Blood."},{"key":"E00006","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ajh.1051","volume":"66","author":"Ruiz-Arg\u00fcelles, GJ","year":"2001","unstructured":"Ruiz-Arg\u00fcelles GJ, G\u00f3mez-Almaguer D, Ruiz-Arg\u00fcelles A, Gonz\u00e1lez-Llano O, Cant\u00fa OG, Jaime-P\u00e9rez JC. Results of an outpatient-based stem cell allotransplant program using non-myeloablative conditioning regimens. Am J Hematol. 2001;66:241-244.","journal-title":"Am J Hematol."},{"key":"E00007","first-page":"894","volume":"87","author":"Ruiz-Arg\u00fcelles, GJ","year":"2002","unstructured":"Ruiz-Arg\u00fcelles GJ, G\u00f3mez-Almaguer D, L\u00f3pez-Mart\u00ednez B, Cant\u00fa-Rodr\u00edguez OG, Jaime-P\u00e9rez JC, Gonz\u00e1lez-Llano O. Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia. Haematologica. 2002;87:894-896.","journal-title":"Haematologica."},{"key":"E00008","first-page":"118","volume":"52","author":"Ruiz-Arg\u00fcelles, GJ","year":"2000","unstructured":"Ruiz-Arg\u00fcelles GJ, Garc\u00e9s-Eisele J, Reyes-N\u00fa\u00f1ez V, et al. Assessment of residual disease in acute leukemia by means of polymerase chain reaction. Rev Invest Clin. 2000;52:118-124.","journal-title":"Rev Invest Clin."},{"key":"E00009","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1517\/14712598.4.10.1693","volume":"4","author":"Ruiz-Arg\u00fcelles, GJ","year":"2004","unstructured":"Ruiz-Arg\u00fcelles GJ, G\u00f3mez-Almaguer D. Breaking dogmata to help patients: non-myeloablative haematopoietic stem cell transplantation. Expert Opin Biol Ther. 2004;4:1693-1699.","journal-title":"Expert Opin Biol Ther."},{"key":"E00010","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1517\/14712598.4.10.1693","volume":"4","author":"Ruiz-Arg\u00fcelles, GJ","year":"2004","unstructured":"Or R, Shapira MY, Resnick I, et al. Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase. Blood. 2003:101:441-445.","journal-title":"Expert Opin Biol Ther."},{"key":"E00011","first-page":"555","volume":"88","author":"Martino, R","year":"2003","unstructured":"Martino R, Giralt S, Caballero MD, et al.Allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning in acute lymphoblastic leukemia: a feasibility study. Haematologica. 2003;88:555-560.","journal-title":"Haematologica."},{"key":"E00012","first-page":"1121","volume":"86","author":"Carella, AM","year":"2001","unstructured":"Carella AM, Beltrami G, Carella M Jr, Corsetti MT, Scalzulli RP, Greco M. Immunosuppressive non-myeloablative allografting as salvage therapy in advanced Hodgkin's disease. Haematologica. 2001;86:1121-1123.","journal-title":"Haematologica."},{"key":"E00013","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1080\/10428190310001642846","volume":"45","author":"Ruiz-Arg\u00fcelles, GJ","year":"2004","unstructured":"Ruiz-Arg\u00fcelles GJ, G\u00f3mez-Almaguer D, G\u00f3mez Rangel JD, et al. Allogeneic hematopoietic stem cell transplantation with non-myeloablative conditioning in patients with acute leukemia eligible for conventional allografting: a prospective study. Leuk Lymphoma. 2004;45:1191-1195.","journal-title":"Leuk Lymphoma."},{"key":"E00014","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/(SICI)1099-1069(199906)17:2<45::AID-HON641>3.0.CO;2-6","volume":"17","author":"Au, WY","year":"1999","unstructured":"Au WY, Kwong YL, Lie AK, Ma SK, Liang R. Extra-medullary relapse of leukemia following allogeneic bone marrow transplantation. Hematol Oncol. 1999;17:45-52.","journal-title":"Hematol Oncol."},{"key":"E00015","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/sj.bmt.1704223","volume":"32","author":"Lee, KH","year":"2003","unstructured":"Lee KH, Lee JH, Choi SJ, et al. Bone marrow vs extramedullary relapse of acute leukemia after allogeneic hematopoietic cell transplantation: risk factors and clinical course. Bone Marrow Transplant. 2003;32:835-842.","journal-title":"Bone Marrow Transplant."},{"key":"E00016","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/sj.bmt.1702488","volume":"26","author":"Lee, KH","year":"2000","unstructured":"Lee KH, Lee JH, Kim S, Lee JS, Kim SH, Kim WK. High frequency of extramedullary relapse of acute leukemia after allogeneic bone marrow transplantation. Bone Marrow Transplant. 2000;26:147-152.","journal-title":"Bone Marrow Transplant."},{"key":"E00017","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/sj.bmt.1702645","volume":"26","author":"Schafer, H","year":"2000","unstructured":"Schafer H, Bader P, Kaiserling E, Klingebiel T, Handgretinger R, Einsele H. Extramedullary relapses at uncommon sites after allogeneic stem cell transplantation. Bone Marrow Transplant. 2000;26: 1133-1135.","journal-title":"Bone Marrow Transplant."},{"key":"E00018","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/10428190009060327","volume":"38","author":"Linn, YC","year":"2000","unstructured":"Linn YC, Goh YT, Tan HC. Relapse of leukemia and lymphoma after marrow transplantation: review of cases with extramedullary relapse. Leuk Lymphoma. 2000;38:137-146.","journal-title":"Leuk Lymphoma."},{"key":"E00019","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/sj.bmt.1701043","volume":"21","author":"Au, WY","year":"1998","unstructured":"Au WY, Chan AC, Lie AK, Chen FE, Liang R, Kwong YL. Recurrent isolated extramedullary relapses as granulocytic sarcomas following allogeneic bone marrow transplantation for acute leukemia. Bone Marrow Transplant. 1998;21:205-208.","journal-title":"Bone Marrow Transplant."},{"key":"E00020","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1182\/blood.V71.3.723.723","volume":"71","author":"Kessinger, A","year":"1998","unstructured":"Kessinger A, Armitage JO, Landmark JD, Smith DM, Weisenburger DD. Autologous peripheral hematopoietic stem cell transplantation restores hemopoietic function following marrow ablative therapy. Blood. 1998;71:723-727.","journal-title":"Blood."},{"key":"E00021","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1200\/JCO.2002.20.2.405","volume":"20","author":"Levine, JE","year":"2002","unstructured":"Levine JE, Braun T, Penza SL, et al. Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation. J Clin Oncol. 2002;20:405-412.","journal-title":"J Clin Oncol."},{"key":"E00022","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1038\/sj.leu.2403523","volume":"18","author":"Choi, SJ","year":"2004","unstructured":"Choi SJ, Lee JH, Lee JH, et al. Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse. Leukemia. 2004;18:1789-1797.","journal-title":"Leukemia."},{"key":"E00023","first-page":"735","volume":"50","author":"Ruiz-Arg\u00fcelles, A","year":"1992","unstructured":"Ruiz-Arg\u00fcelles A. Flow cytometry in the clinical laboratory: principles, applications and problems. Ann Biol Clin. 1992;50:735-743.","journal-title":"Ann Biol Clin."},{"key":"E00024","first-page":"79","author":"Ruiz-Arg\u00fcelles, A","year":"1996","unstructured":"Ruiz-Arg\u00fcelles A, Orfao A. Caracterizaci\u00f3n y evaluaci\u00f3n de c\u00e9lulas totipotenciales en sangre perif\u00e9rica y m\u00e9dula \u00f3sea. In: RuizArg\u00fcelles GJ, San-Miguel JF, eds. Actualizaci\u00f3n en Leucemias. M\u00e9xico City, Mexico: Editorial M\u00e9dica Panamericana; 1996:79-82."},{"key":"E00025","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1080\/10428190290033549","volume":"43","author":"Ruiz-Arg\u00fcelles, GJ","year":"2002","unstructured":"Ruiz-Arg\u00fcelles GJ, L\u00f3pez-Mart\u00ednez B, Santell\u00e1n-Olea MR, et al. Follow up of hemopoietic chimerism in individuals given allogeneic hemopoietic stem cell allografts using an immunosuppressive, non-myeloablative conditioning regimen: a prospective study in a single institution. Leuk Lymphoma. 2002;43:1509-1511.","journal-title":"Leuk Lymphoma."},{"key":"E00026","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1073\/pnas.83.9.2934","volume":"83","author":"Pinkel, D","year":"1986","unstructured":"Pinkel D, Straume T, Gray JW. Cytogenetic analysis using quantitative, high sensitivity, fluorescence hybridization. Proc Natl Acad Sci U S A. 1986;83:2934-2938.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"E00027","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00007890-198703000-00016","volume":"43","author":"Yam, P","year":"1987","unstructured":"Yam P, Petz L, Knowlton R, et al. Use of DNA restriction fragment length polymorphisms to document marrow engraftment and mixed hematopoietic chimerism following bone marrow transplantation. Transplantation. 1987;43:399-407.","journal-title":"Transplantation."}],"container-title":["International Journal of Hematology"],"original-title":[],"link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1532\/IJH97.04195","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T02:03:48Z","timestamp":1586484228000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1532\/IJH97.04195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,1]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,10,1]]}},"alternative-id":["54M8TKPXYM520U3Q"],"URL":"https:\/\/doi.org\/10.1532\/ijh97.04195","relation":{},"ISSN":["0925-5710"],"issn-type":[{"value":"0925-5710","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10,1]]}}}